RxDoctor Payments Data

Zaccary Pincock, OD

Optometrist · Fircrest, WANPI 1063064541

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.5%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. Alcon accounts for 83.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $1,843 and has fallen 88.4% since, to $214 in 2025.

$2,460in general payments, 2019–2025

Across 46 payments — averaging $53.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$2K
  • Coopervision Inc.$133
  • Biotissue Holdings Inc.$87
  • Bausch & Lomb Americas Inc.$82
  • Carl Zeiss Meditec AG$39
  • Sun Pharmaceutical Industries Inc.$33
  • plus $33 from 2 others

What the payments were for

  • Travel & lodging$1,17848%
  • Food & beverage$1,24351%
  • Gifts$392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,460 in reported general payments places this provider in the 85th percentile of 1,267 optometrist providers in Washington.

See all optometrist providers in Washington →

Medicare billing

Part B allowed, 2024
$20,288
Medicare patients
109
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate14$413
Latanoprost11$37

Paid to pharmacies, not to this prescriber.

Other optometrist in Fircrest

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →